JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 6,250.00
-130.00 (-2.04%)
Sep 17, 2025, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 224.12 billion as of September 17, 2025. Its market cap has decreased by -24.40% in one year.
Market Cap
224.12B
Enterprise Value
320.45B
Revenue
70.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,250.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 224.12B, an increase of 73.59%. That is a compound annual growth rate of 9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 224.12B | -19.19% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | 402.27B | 139.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.88T |
| Celltrion | 37.82T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,955.07B |
| SK Biopharmaceuticals | 8,692.77B |
| Peptron | 7,152.29B |
| PharmaResearch | 6,690.93B |
| ABL Bio | 5,746.76B |